Most laboratories have begun using polymerase chain reaction assays, or the PCR technique, as opposed to enzyme-linked immunosorbent assay detection, also known as ELISA testing, to diagnose ...

Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure. Early testing facilitates prompt diagnosis and management, influencing ...

FMT restores gut microbiota balance by transferring stool from healthy donors, mainly for recurrent C. difficile infections. Recent data shows FMT's high efficacy in preventing recurrent C. difficile, ...

Nearly 10 percent of patients were infected with Clostridium difficile when they entered a Minnesota hospital, according to a study in the American Journal of Infection Control. Researchers studied ...

Doctors typically consider testing for C. diff when a patient has persistent diarrhea after recent antibiotic use, particularly if they have other risk factors such as hospitalization or taking ...

Twenty-six percent of patients with a recent Clostridium difficile infection received only unnecessary antimicrobials, according to a study in Infection Control and Hospital Epidemiology. Researchers ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

The CDC provides a free online video for healthcare providers on testing for Clostridium difficile. In the video, Dr. Carolyn Gould, a medical epidemiologist in the Division of Healthcare Quality ...

Please provide your email address to receive an email when new articles are posted on . More patients in the bezlotoxumab group experienced recurrence vs. the placebo group (13% vs. 3%). Steroid use ...

STATEN ISLAND, N.Y., Dec. 9, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...